Expression and characterization of Helicobacter pylori adhesin protein linked to cholera toxin A2/B subunits in Escherichia coli

Journal of Microbiology and Biotechnology

Volumn 10, Issue 1, 2000, Pages 56-62

  Kim, Byung Oh ^a   Shin, Sung Seup ^b   Yoo, Young Hyo ^b   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Daewoong Pharmaceutical Co Ltd   (South Korea)

Author keywords

Adhesin CTXA2B; CTXA2B; Helicobacter pylori adhesin

Indexed keywords

ADHESIN; BACTERIAL ANTIGEN; CHOLERA TOXIN; HYBRID PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL GENE; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE FUSION; HELICOBACTER PYLORI; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; VACCINE PRODUCTION;

ESCHERICHIA COLI; HELICOBACTER PYLORI;

EID: 6744222834     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Blaser, M. J. 1990. Epidemiology and pathophysiology of Campylobacter pylori infections. Rev. Infect. Dis. 12: S99-S106.
2. Bruno, G., M. Catherine, F. Sophine, H. Jean, V. L. Elisabeth, and R. Bachre. 1998. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16: 850-856.
3. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. Holmgren. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57: 1072-1081.
4. Czinn, S. J., A. Cai, and J. G. Nedrud. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11: 637-642.
5. Evans, D. G., T. K. Karjalainen, D. G. Evans Jr., D. Y. Graham, and C. H. Lee. 1993. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J. Bacteriol. 175: 674-683.
6. Evans, D. J., D. G. Evans, K. E. Smith, and D. Y. Graham. 1989. Serum antibody responses to the N-acetylneuraminyllactose-binding of Campylobacter pylori. Infect. Immun. 57: 664-667.
7. Hajishengallis, G., S. K. Hollingshead, T. Koga, and M. W. Russell. 1995. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunology 154: 4322-4332.
8. Glupczynski, Y., A. Burette, H. Goossens, C. DePrez, and J. P. Butzler. 1992. Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur. J. Clin. Microbiol. Infect. Dis. 11: 583-588.
9. Glupczynski, Y. and A. Burette. 1992. Eradicating Helicobacter pylori. Lancet 339: 54-55.
10. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature 292: 413-417.
11. th International Workshop on Campylobacter, Helicobacter and Related Organisms. Central Veterinary Laboratory, Winchester, United Kingdom, U.K.
12. Lee, K. K., J. S. Son., Y. J. Chang., S. U. Kim, and K. H. Kim. 1998. Separate expression and in vitro activation of recombinant Helicobacter pylori urease structural subunits. J. Microbiol. Biotechnol. 8: 700-704.
13. Lingwood, C. A., G. Wasfy, H. Han, and M. Huesca. 1993. Receptors affinity purification of a lipid-binding adhesion from Helicobacter pylori. Infect. Immun. 61: 2474-2478.
14. Lingwood, C. A. 1993. Helicobacter pylori: Receptors and adhesins. pp. 209-222. In Goodwin, C. S. and B. W. Worsley (eds.), Helicobacter pylori: Biology and Clinical Practice. CRC Press Inc., Boca Raton, FL, U.S.A.
15. Majewski, S. I. H. and C. S. Goodwin. 1988. Restriction endonuclease analysis of the genome of Camphylobacter pylori with a rapid extraction method: Evidence for considerable genomic variation. J. Infect. Dis. 157: 465-471.
16. Marshall, B. J., H. Royce, D. I. Annear, C. S. Goodwin, J. W. Pearman, J. R. Warren, and J. A. Armstron. 1984. Original isolation of Campylobacter pylordis from human gastric mucosa. Microbios. Lett. 25: 83-88.
17. Marston, F. A. O. 1986. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J. 240: 1-8.
18. McKenzie, S. J. and J. F. Halsey. 1984. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 133: 1818-1823.
19. Mekalanos, J. J., D. J. Swartz, G. D. N. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: Nucleotide sequence, deletion analysis and vaccine development. Nature 306: 551-559.
20. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune response in external secretions. J. Clin. Immunol. 7: 265-272.
21. Michetti, M., M. Rossi, V. Giannelli, M. M. Giuliani, M. Pizza, S. Censini, A. Covacci, P. Massari, C. Pagliaccia, R. Manetti, J. L. Telford, G. Douce, G. Dougan, R. Rappuoli, and P. Ghiara. 1998. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16: 33-37.
22. Park, M. H., S. K. Park, Y. H. Yu, Y. W. Koh, C. H. Kown, S. H. Kim, J. Y. Jung, S. W. Yoon, and T. Y. Koo. 1995. Large-scale production of recombinant human epidermal growth factor and its development as a new drug, pp. 63-72. Proceedings of International Symposium on R&D in the Pharmaceutical Industry of Korea and Hungary, Budapest, Hungary.
23. Philippe, S. D., S. N. Accart, H. V. J. Kolbe, D. Schubnel, B. Bernadette, R. Bischoff, and K. Marie-Paule. 1994. Recombinant cholera toxin B subunit in Escherichia coli: High-level secretion, purification, and characterization. Protein Expres. Purif. 5: 518-526.
24. Russell, M. W. and H. Y. Wu. 1991. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect. Immun. 59: 4061-4074.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., U.S.A.
26. Taylor, D. N. and M. J. Blaser. 1991. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev. 13: 42-59.
27. Telford, J. L., A. Covacci, P. Ghiara, C. Montecucco, and R. Rappuoli. 1994. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer; potential for new therapies and vaccines. Trends Biotechnol. 12: 420-426.
28. Wu, H. Y. and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61: 314-320.